Georgia Medicaid Prescription Drug Coverage (2026): PDL & Copays

For most Georgia Medicaid members, prescription drugs are the single most frequently used Medicaid benefit. A senior with hypertension fills a Lisinopril prescription every month. A child with ADHD fills a methylphenidate prescription every month. A pregnant woman fills a prenatal vitamin every month. A man recovering from opioid use disorder fills a buprenorphine prescription every month. Over the course of a year, a typical Medicaid member fills more pharmacy claims than they have visits to all other providers combined.

Who administers your Georgia Medicaid pharmacy benefit depends on how you are enrolled. If you are in the fee-for-service (FFS) program, your outpatient pharmacy claims are processed by OptumRx, the Pharmacy Benefits Manager that Georgia's Department of Community Health (DCH) uses for the Medicaid Fee For Service Outpatient Pharmacy Program. If you are enrolled in a Georgia Families Care Management Organization (CMO), your pharmacy benefit runs through your CMO and its own pharmacy benefit manager. One name you will see throughout Georgia Medicaid is Gainwell Technologies, but Gainwell is the state's GAMMIS/MMIS fiscal agent and member contact center (member services 1-866-211-0950), not a statewide pharmacy benefit manager that processes every prescription.

That distinction matters when something goes wrong at the pharmacy counter. A fee-for-service member with a rejected claim is dealing with the OptumRx-administered FFS benefit and DCH policy; a CMO member is dealing with their plan's pharmacy benefit. There is no single statewide pharmacy benefit manager that all Georgia Medicaid prescriptions flow through. The underlying clinical rules, though, are highly consistent, because DCH sets a statewide Preferred Drug List and prior authorization framework that the FFS program follows and the CMOs align to.

This guide explains the federal Medicaid drug rebate framework under 42 USC 1396r-8, how Georgia's pharmacy benefit is administered (OptumRx for fee-for-service, the CMO for managed-care members, Gainwell as fiscal agent), the Preferred Drug List, prior authorization rules including the 72-hour emergency supply requirement, generic substitution, copays, mail-order and specialty pharmacy, opioid stewardship under the SUPPORT Act of 2018, EPSDT pediatric drug coverage, the interaction with Medicare Part D for dual-eligibles, and how to appeal a denied prescription.

Key Takeaways

• Georgia does not use a single statewide pharmacy benefit manager. For fee-for-service members, OptumRx is the Pharmacy Benefits Manager that processes outpatient pharmacy claims; for Georgia Families CMO members, the pharmacy benefit runs through the CMO and its PBM. Gainwell Technologies is the state's GAMMIS/MMIS fiscal agent and member contact center, not the pharmacy benefit manager.
• Federal authority for Medicaid drug coverage is 42 USC 1396d(a)(11) (optional service, every state elected) and 42 USC 1396r-8 (Drug Rebate Program from OBRA-90).
• Georgia maintains a statewide Preferred Drug List (PDL) updated quarterly by the DCH Pharmacy and Therapeutics Committee. Preferred drugs do not require prior authorization; non-preferred drugs do. The FFS program follows the DCH PDL, and the CMOs align their formularies to it.
• Member copays in 2026: nominal amounts for generic and brand drugs. Children, pregnant women, NF residents, hospice patients, and emergency drugs are exempt from copays.
• Mandatory generic substitution applies. "Dispense as written" for brand requires prior authorization with medical necessity justification.
• Federal law at 42 USC 1396r-8(d)(4)(B) requires pharmacies to dispense a 72-hour emergency supply if PA is pending and the prescriber is unavailable.
• Opioid stewardship: 7-day initial supply limit for opioid-naive patients, MME thresholds trigger PA, GA PDMP check required for controlled substances, naloxone covered through standing order.
• Dual-eligibles use Medicare Part D for drug coverage, NOT Medicaid pharmacy. Full duals are auto-deemed for LIS Extra Help, which significantly reduces Part D copays.

The federal framework: rebates, PDLs, and PA

Prescription drugs are an optional service under federal Medicaid law at 42 USC 1396d(a)(11). Every state has elected to cover them. The optionality reflects the original 1965 design; in practice, drug coverage is universal because health care is impossible without it.

The Medicaid Drug Rebate Program, codified at 42 USC 1396r-8 and added by OBRA-90 (P.L. 101-508), is the financial backbone of Medicaid drug coverage. Drug manufacturers wishing to have their products covered by Medicaid must sign a rebate agreement with CMS. Under the agreement, the manufacturer pays a rebate to the state for every Medicaid prescription dispensed. The rebate has two components:

• Basic rebate: a percentage of the average manufacturer price (AMP) for most brand drugs, increased by the ACA in 2010
• Inflationary rebate: additional rebate when the AMP rises faster than inflation

For generics, the basic rebate rate differs from brand drugs. Some specialty categories have different rebate structures.

Federal law at 42 USC 1396r-8(d)(6) authorizes states to operate a Preferred Drug List. The PDL identifies preferred drugs within each therapeutic class. Non-preferred drugs may be subject to prior authorization. Federal law at 42 USC 1396r-8(d)(4) sets minimum standards for PA: decisions must be made within 24 hours of receipt of complete information, and a 72-hour emergency supply must be available if PA is pending.

Federal drug utilization review (DUR) requirements at 42 USC 1396r-8(g) require every state to operate prospective DUR (point-of-sale checks for interactions, duplications, age/sex contraindications) and retrospective DUR (periodic review of utilization patterns).

The ACA in 2010 extended the rebate program to drugs dispensed under Part D for dual-eligibles. The Bipartisan Budget Act of 2015 made other adjustments. The Inflation Reduction Act of 2022 created drug price negotiation for Medicare, with limited direct effect on Medicaid (because Medicaid already has rebates).

How Georgia administers the pharmacy benefit

Georgia Medicaid does not run all of its pharmacy claims through one statewide pharmacy benefit manager. Instead, who administers your pharmacy benefit depends on how you are enrolled. There are two main tracks, plus a fiscal agent that ties the whole Medicaid system together.

Fee-for-service (FFS): OptumRx. Members in traditional fee-for-service Medicaid, which includes much of the Aged, Blind, and Disabled (ABD) population and certain other groups, have their outpatient pharmacy benefit administered by OptumRx. Per DCH, OptumRx is the Pharmacy Benefits Manager for the Georgia Medicaid Fee For Service Outpatient Pharmacy Program. OptumRx processes FFS outpatient pharmacy claims at the point of sale and pays enrolled pharmacy providers (DCH describes payment to enrolled pharmacies on a weekly cycle).

Georgia Families CMO members: the CMO and its PBM. Members enrolled in a Georgia Families CMO receive their pharmacy benefit through their CMO, which contracts with its own pharmacy benefit manager. These members do not use OptumRx for pharmacy; their claims are processed under their plan's pharmacy benefit. As of 2026, Georgia Families has three current CMOs: Amerigroup Community Care, CareSource, and Peach State Health Plan. (Rosters can change; the current three-CMO contracts have been extended while a reprocurement is resolved, so confirm your plan's pharmacy contact on your member ID card.)

Gainwell Technologies: the fiscal agent, not the PBM. Gainwell Technologies is Georgia's GAMMIS/MMIS fiscal agent and the Medicaid member contact center (member services 1-866-211-0950). It runs the Medicaid claims-and-eligibility system and answers member questions, but it is not the statewide pharmacy benefit manager and it does not adjudicate every Georgia Medicaid prescription. Earlier descriptions of a single statewide pharmacy benefit manager (SPBM) running all Medicaid pharmacy claims through Gainwell do not reflect the current arrangement.

The CMO (or FFS) is relevant for primary care, specialty care, hospital, and other covered services. For pharmacy, the practical takeaway is to know which track you are on: FFS members work with the OptumRx-administered benefit and DCH policy, while CMO members work with their plan. The clinical rules are consistent across tracks because DCH publishes a statewide Preferred Drug List and prior authorization framework.

How a prescription gets filled in Georgia in 2026

Step by step:

1. Member receives a prescription from a Medicaid-enrolled prescriber. The prescriber may write paper, transmit e-prescribing, or call/fax the pharmacy.
2. Member presents at a Medicaid-enrolled pharmacy with their Georgia Medicaid card or CMO card (the pharmacy uses it to route the claim to the right processor).
3. Pharmacy submits the claim to the right pharmacy processor. For an FFS member, the claim goes to OptumRx; for a CMO member, it goes to the CMO's pharmacy benefit manager. Adjudication is real-time at the point of sale.
4. The processor adjudicates. Checks include: member active Medicaid status, drug on the PDL (preferred vs non-preferred), age/sex appropriateness, drug interactions, dose limits, quantity limits, PA status, DUR alerts, copay tier.
5. Adjudication response:
   • Approved: pharmacy dispenses; member pays applicable copay (nominal per prescription, or $0 if exempt)
   • Rejected with reason code: pharmacy reviews the reason, may rerun with corrections (e.g., switch to generic, request 72-hour emergency supply, refer to prescriber for PA)
   • PA required: prescriber must submit PA before dispensing; emergency 72-hour supply may be dispensed in interim
6. The plan settles payment. For FFS members, OptumRx processes the claim and DCH pays enrolled pharmacies. For Georgia Families CMO members, the CMO capitation includes pharmacy and the CMO's PBM pays the pharmacy.

The member does not see the financial flow; they pay the copay and walk out with the drug.

The Preferred Drug List

Georgia's PDL is the single biggest determinant of which drugs are easy to fill and which require extra steps. The PDL is maintained by the DCH Pharmacy and Therapeutics (P&T) Committee, which meets quarterly to review therapeutic classes.

The P&T Committee evaluates:

• Clinical evidence: efficacy, safety, FDA labeling, head-to-head trials, comparative effectiveness research
• Supplemental rebate offers: manufacturers may offer rebates above the federal floor in exchange for preferred status
• Total net cost: drug cost minus rebates compared to alternatives
• Patient access: ensuring at least one preferred agent per major class

The PDL is published quarterly with updates posted to the DCH Georgia Medicaid pharmacy program portal. Examples of typical preferred-non-preferred decisions:

• ACE inhibitors: Lisinopril (preferred), most others (non-preferred); brand-only agents typically non-preferred
• PPIs: omeprazole and pantoprazole (preferred); newer brands like Nexium (non-preferred or DAW only)
• SSRIs: sertraline, fluoxetine, citalopram, escitalopram (preferred); brand Lexapro or Prozac (non-preferred)
• Atypical antipsychotics: risperidone, olanzapine, quetiapine generics (preferred); brand newer agents (non-preferred or PA)
• Insulins: specific products preferred based on contract; some brand-only available with PA
• GLP-1 agonists: typically PA-restricted to diabetes use, not weight loss

The PDL allows "open access" in certain classes where clinical practice demands choice (e.g., anticonvulsants, antiretrovirals, some oncology, certain mental health agents). Open access drugs are typically available without PA.

Prior authorization in detail

Several PA pathways exist:

Non-preferred drug PA. When a non-preferred drug is requested, prescriber submits PA with clinical justification: why preferred alternatives are inadequate (failed trial, contraindication, intolerance), what condition is being treated, what dose/duration, expected outcome.

Step therapy PA. Some classes require documented trial and failure of (or contraindication to) one or more preferred agents before non-preferred is approved.

Specialty drug PA. Biologics, oncology, MS DMTs, hepatitis C DAAs, growth hormone, transplant immunosuppressants, and similar high-cost drugs typically require PA regardless of PDL status. Specialty PA includes clinical criteria, laboratory values, diagnostic criteria, prior therapy.

Quantity or duration limit PA. Opioids beyond 7-day initial naive supply, benzodiazepines beyond duration thresholds, stimulants in adults, sleep medications in chronic use.

DAW brand PA. "Dispense as written" requests when bioequivalent generic exists require justification: documented adverse reaction to generic, narrow therapeutic index, FDA-recognized non-substitution (rare cases).

Age-restricted PA. Growth hormone in adults, gender-affirming hormones for adolescents, certain pediatric off-label uses.

PA timing

Federal law at 42 USC 1396r-8(d)(4) requires:

• Standard PA decision: within 24 hours of receipt of complete information
• 72-hour emergency supply: pharmacist may dispense if PA is pending and prescriber unavailable

If the pharmacy benefit does not respond within 24 hours, the request is deemed approved (with documentation requirements).

PA appeals

If PA is denied:

1. Prescriber can resubmit with additional clinical information
2. Internal appeal through the plan that administers the benefit (OptumRx/DCH for FFS, or the CMO for managed-care members) within the applicable timeframe
3. Member can request external appeal through OSAH within 30 days of final denial
4. Expedited 72-hour appeal for life-threatening situations

Mandatory generic substitution

Federal Medicaid law and Georgia DCH policy require pharmacists to substitute a bioequivalent generic drug for a brand prescription whenever an FDA-rated AB-equivalent generic exists. The exceptions:

• Prescriber writes DAW (dispense as written) or "brand medically necessary": pharmacist must dispense the brand IF PA approves the DAW request
• No generic exists: pharmacist dispenses the brand at brand copay

DAW PA approval requires the prescriber to document a clinical reason for brand: documented adverse reaction to generic, narrow therapeutic index drug (some seizure medications, warfarin, levothyroxine in specific cases), or FDA-recognized substitution restriction.

In practice, most DAW requests are denied. The Medicaid program is cost-conscious and generic equivalents are clinically interchangeable for most drugs.

Member copays in 2026

Georgia Medicaid pharmacy copays are nominal:

• Generic: nominal copay per prescription
• Brand: nominal copay per prescription
• OTC drugs on the OTC PDL: nominal copay
• Exempt populations: $0

Exempt populations include:

• Children under 21 (no pharmacy copay under EPSDT)
• Pregnant women and women in the 60-day to 12-month postpartum window
• Inpatient hospital stays (drugs included in the inpatient rate)
• Hospice patients
• Emergency drugs
• Family planning drugs (contraceptives, related supplies)
• Drugs for tuberculosis treatment
• American Indians and Alaska Natives receiving services through IHS or tribal providers

Federal law caps total cost-sharing at 5% of household income aggregated across all services. Pharmacy is included in the cap. The pharmacy cannot refuse to dispense a covered prescription if the member is unable to pay the nominal copay.

Mail-order pharmacy

GA Medicaid allows mail-order pharmacy for maintenance medications. Major mail-order pharmacies participate in the Medicaid pharmacy network (the FFS network administered by OptumRx, or the CMO's network for managed-care members). Mail-order is useful for:

• Stable maintenance medications (blood pressure, cholesterol, thyroid, diabetes)
• 90-day supplies (one shipment covers three months)
• Specialty drugs (cold-chain, oncology, biologics)
• Members in rural areas without easy pharmacy access

Mail-order copay: same per-fill copay structure as retail, often applied as a single per-fill copay regardless of 30 vs 90 day supply.

Specialty pharmacy

Specialty drugs are typically high-cost biologics, oncology, MS, hepatitis C, HIV, immunology, growth hormone, and similar. Specialty pharmacies in the Medicaid network (the FFS network administered by OptumRx, or the member's CMO network) handle these drugs through dedicated specialty pharmacy networks.

Specialty pharmacy services include:

• PA coordination with prescriber
• Cold-chain shipping (insulin, biologics)
• Patient education and adherence monitoring
• Refill management
• Coordination with prescriber for renewals
• 24/7 clinical support line

Many specialty drugs are not available at retail pharmacies and must be filled through specialty.

Opioid stewardship

The SUPPORT Act of 2018 (P.L. 115-271) imposes opioid utilization controls on every state Medicaid program. Georgia implements these through several mechanisms.

7-day initial supply limit for opioid-naive patients. A patient with no recent opioid prescription is "opioid-naive." The SUPPORT Act limits initial opioid prescriptions to 7 days for naive patients. Renewal requires reassessment.

Morphine milligram equivalent (MME) thresholds. GA Medicaid sets MME thresholds that trigger PA. Higher daily MME doses require progressively more clinical justification. Functional assessment, opioid risk assessment, urine drug screening, and pain management plan documentation may be required.

GA Prescription Drug Monitoring Program (PDMP). Georgia prescribers must check the GA PDMP before prescribing any controlled substance. The PDMP database tracks every controlled substance prescription in Georgia and flags patterns of multiple prescribers, multiple pharmacies, or escalating doses.

Naloxone access. GA Medicaid covers naloxone (Narcan, Kloxxado) for high-risk patients and family members. Under the Georgia standing order from the Department of Public Health, pharmacies may dispense naloxone without a patient-specific prescription.

MAT (Medication-Assisted Treatment) for opioid use disorder. Methadone and buprenorphine (Suboxone) for opioid use disorder are covered with minimal PA barriers. Buprenorphine is preferred for office-based treatment. Methadone is covered through licensed opioid treatment programs (methadone clinics).

Lock-in program. Members with patterns suggesting controlled substance misuse may be assigned to a single prescriber and single pharmacy for controlled substances. The lock-in restricts where the member can obtain controlled substances without affecting other prescriptions.

Drug Utilization Review

Georgia Medicaid operates prospective and retrospective DUR. For fee-for-service claims, point-of-sale and retrospective DUR run through the OptumRx-administered FFS benefit under DCH oversight; CMOs run DUR for their own members. DCH maintains a Drug Utilization Review Board for the program.

Prospective DUR runs at the point of sale. Every claim is screened for therapeutic duplication (two drugs in the same class), drug-drug interactions, drug-allergy interactions, age/sex contraindications, dose-range checks, and refill-too-soon alerts. The pharmacist receives DUR alerts and may need to consult with the prescriber before dispensing.

Retrospective DUR runs periodically on claims data. The DUR Board reviews utilization patterns to identify outliers (members receiving unusually high doses, multiple prescribers, drug-disease mismatches), prescriber education needs, and quality improvement opportunities. Outreach to prescribers may follow.

Dual-eligibles: Medicare Part D, not Medicaid pharmacy

For dual-eligibles (members with both Medicare and Medicaid), prescription drugs are covered under Medicare Part D, not Medicaid. Federal law prohibits Medicaid from paying for drugs that are covered under Part D for these members.

Full dual-eligibles are auto-deemed for the Low-Income Subsidy (LIS or Extra Help) under 42 USC 1395w-114. LIS dramatically reduces Part D costs. In 2026, LIS copays are:

• No copay for institutionalized full duals (in NF or ICF/IID)
• Low copays for full duals at or below 100% FPL
• Higher copays for full duals above 100% FPL or partial-LIS-eligible
• No copay for hospice-dual

The Inflation Reduction Act of 2022 introduced annual caps on Part D out-of-pocket spending starting in 2025, including a monthly cap on insulin costs. LIS Extra Help generally results in lower copays than the IRA caps.

Some drugs are NOT covered under Part D but are covered under Medicaid as wraparound for dual-eligibles. Examples:

• Certain over-the-counter drugs (cough/cold, vitamins, antacids) when on Medicaid OTC list
• Cosmetic drugs (rarely)
• Fertility drugs (typically excluded from both)
• Weight loss/gain drugs (typically excluded)
• Cough/cold prescription drugs (often excluded from Part D)
• Drugs related to family planning (Medicaid coverage with $0 copay)

For more on dual-eligible coverage, see the Georgia Medicare Savings Programs guide.

EPSDT pediatric drug coverage

Under 42 USC 1396d(r)(5), prescription drugs are part of EPSDT for children under 21. The EPSDT trump card applies: medically necessary drugs for children must be covered even if otherwise restricted for adults.

Practical examples:

• A child needs a non-PDL ADHD medication that is non-preferred for adults. EPSDT supports coverage with medical necessity documentation.
• A child needs a compounded medication when the commercial product is not appropriate (specific allergens, dose adjustments). Compounded pediatric medications are typically covered.
• A child needs off-label use supported by evidence and recommended by AAP or pediatric specialty society. EPSDT supports coverage.

Pediatric copay is $0 under EPSDT.

What is NOT covered

A few categories of drugs are not covered:

• Drugs from manufacturers without rebate agreements. Rare; most manufacturers participate.
• Cosmetic drugs. Botox for cosmetic use, hair restoration, etc.
• Fertility drugs. With rare exceptions.
• Weight loss drugs. GLP-1 agonists are covered for diabetes (with PA) but not for weight loss alone. The IRA-era anti-obesity coverage expansion in Medicare has not been adopted in Georgia Medicaid.
• Investigational or experimental drugs not FDA-approved.
• Sexual dysfunction drugs (with limited exceptions for medical conditions like pulmonary hypertension).
• Vaccines for children are covered through the Vaccines for Children (VFC) program at federal cost; Medicaid pays only the administration fee.

Frequently Asked Questions

How do I fill a prescription on Georgia Medicaid?

Bring your prescription and your Georgia Medicaid or CMO card to any Medicaid-enrolled pharmacy in Georgia. The pharmacy submits the claim to the processor that administers your benefit: OptumRx if you are in fee-for-service Medicaid, or your CMO's pharmacy benefit manager if you are in a Georgia Families plan. If the drug is on the Preferred Drug List, the claim is approved at the point of sale. You pay the applicable copay (nominal per prescription) and receive the medication. If prior authorization is required, the prescriber will need to submit a PA before the prescription can be filled, but the pharmacy may dispense a 72-hour emergency supply in the interim.

Who administers the Georgia Medicaid pharmacy benefit?

It depends on how you are enrolled. For fee-for-service members, OptumRx is the Pharmacy Benefits Manager for the Georgia Medicaid Fee For Service Outpatient Pharmacy Program; it processes FFS outpatient pharmacy claims at the point of sale. For Georgia Families CMO members, the pharmacy benefit runs through the CMO and its own PBM. Gainwell Technologies is Georgia's GAMMIS/MMIS fiscal agent and member contact center (1-866-211-0950), not a single statewide pharmacy benefit manager that processes every prescription. The clinical rules are consistent across tracks because DCH publishes a statewide Preferred Drug List and prior authorization framework.

What is the Preferred Drug List?

The PDL is the list of drugs preferred for first-line use within each therapeutic class. Drugs on the PDL are dispensed without prior authorization. Drugs not on the PDL ("non-preferred") require PA before dispensing. The PDL is maintained by the DCH Pharmacy and Therapeutics Committee, which meets quarterly, and is published on the DCH Georgia Medicaid pharmacy program portal.

How much do prescriptions cost on Georgia Medicaid?

Nominal copays apply per prescription. Children under 21, pregnant women, NF residents, hospice patients, and members receiving emergency or family planning drugs have $0 copay. Federal law caps total cost-sharing at 5% of household income, and pharmacies cannot refuse to dispense if you cannot pay the nominal copay.

How does prior authorization work?

If a prescription requires PA, the prescriber submits clinical justification to the plan that administers the benefit (OptumRx/DCH for FFS members, or the CMO for managed-care members). The decision must be made within 24 hours of receiving complete information. Approval means the prescription is filled normally. Denial can be appealed. If PA is pending and the prescriber is unavailable, the pharmacist may dispense a 72-hour emergency supply under federal law at 42 USC 1396r-8(d)(4)(B). For life-threatening situations, expedited 72-hour PA review and appeal are available.

Does Georgia Medicaid cover brand drugs when I want them?

Only if the prescriber writes "dispense as written" (DAW) and the plan approves the DAW PA. Medicaid law requires generic substitution where an FDA-rated bioequivalent generic exists. DAW for brand requires the prescriber to document medical necessity (documented adverse reaction to generic, narrow therapeutic index drug, FDA non-substitution status). Most DAW requests are denied because generics are clinically interchangeable for most drugs.

What about insulin and diabetes medications?

Insulin is covered with the specific products on the PDL. Some insulins are preferred, others require PA. Diabetes oral medications (metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 agonists with PA for diabetes use) are largely covered. Diabetes supplies (glucose meters, test strips, lancets, CGM in some cases) are covered through DME. For dual-eligibles, Medicare Part D covers insulin with IRA monthly cost caps; LIS Extra Help may reduce further.

What about opioids?

Georgia implements opioid stewardship under the SUPPORT Act of 2018. The initial supply for opioid-naive patients is limited to 7 days. Higher daily MME doses trigger PA. Prescribers must check the Georgia Prescription Drug Monitoring Program (PDMP) before prescribing any controlled substance. Naloxone is covered under a Georgia standing order, available at pharmacies without an individual prescription. MAT for opioid use disorder (methadone, buprenorphine) is covered with minimal PA barriers.

How do prescriptions work for dual-eligibles?

For members with both Medicare and Medicaid, prescription drugs are covered under Medicare Part D, not Medicaid. Full dual-eligibles are auto-deemed for the Low-Income Subsidy (LIS or Extra Help), which dramatically reduces Part D copays to $0 for institutionalized members and nominal amounts for community-living full duals. Some drugs not covered by Part D (certain OTCs, family planning, others) may be covered by Medicaid as wraparound.

What if my prescription is denied?

First, ask the pharmacy for the rejection reason code. Common reasons: PA required, refill too soon, quantity limit exceeded, drug not on formulary, member eligibility issue. If PA is required, your prescriber submits it to the plan that administers your benefit (OptumRx/DCH for FFS, or your CMO). If you cannot reach the prescriber, the pharmacy can dispense a 72-hour emergency supply. If the PA is denied, your prescriber can resubmit with additional clinical information, request an internal appeal, or you can request an external appeal through OSAH within 30 days. For life-threatening situations, expedited appeal with 72-hour decision is available.

Worked example 1: Mrs. Anderson, 67, dual-eligible

Mrs. Anderson has hypertension and type 2 diabetes. She is on Medicare and Georgia Medicaid (QMB-Plus dual). Her drug coverage is through Medicare Part D, not Medicaid pharmacy.

Her medications and LIS Extra Help copays in 2026:

• Lisinopril 10 mg daily: LIS generic copay applies
• Metformin 500 mg twice daily: LIS generic copay applies
• Atorvastatin 20 mg daily: LIS generic copay applies
• Glargine insulin: LIS may apply, with the IRA monthly insulin cap as fallback
• Hydrochlorothiazide 12.5 mg daily: LIS generic copay applies

Total monthly drug cost: very low. She uses her Part D plan card at the pharmacy, not her Medicaid card. The Medicaid pharmacy benefit does not apply to her drugs.

Worked example 2: Mr. Davis, 38, Pathways to Coverage, anxiety + opioid use disorder recovery

Mr. Davis is on Pathways to Coverage and is in recovery from opioid use disorder. His medications:

• Sertraline 100 mg daily (anxiety, depression): Generic preferred, no PA, nominal copay per fill
• Buprenorphine-naloxone (Suboxone) 8-2 mg sublingual films, twice daily for MAT: Generic preferred, no PA, nominal copay per fill; ongoing MAT supports recovery
• Trazodone 50 mg at bedtime (insomnia): Generic preferred, no PA, nominal copay per fill

Mr. Davis fills monthly at a community pharmacy. Total monthly out-of-pocket is minimal.

When his anxiety worsens and his psychiatrist prescribes a benzodiazepine (alprazolam), the PA is reviewed against opioid co-prescribing risk. Because of the buprenorphine, the prescriber documents medical necessity, short-term use, and risk mitigation. PA is approved for 30 days with quarterly reassessment.

Worked example 3: Mrs. Smith, 28, pregnant

Mrs. Smith is 28, pregnant, and on Georgia Medicaid pregnancy coverage. Her medications and supplies:

• Prenatal vitamin daily: $0 copay (pregnant exempt)
• Doxylamine-pyridoxine for nausea: $0 copay
• Ondansetron (Zofran) ODT for severe nausea episodes: $0 copay
• Iron supplement: $0 copay

All medications are filled at her community pharmacy through her Medicaid pharmacy benefit. No PA required. Cost to Mrs. Smith: $0. Her pregnancy and 12-month postpartum coverage extends the $0 copay window.

Worked example 4: Tommy, 8, ADHD

Tommy is 8, enrolled in Amerigroup (Georgia Families) and was recently diagnosed with ADHD by his pediatrician.

Medications:

• Methylphenidate ER (generic Concerta) 18 mg daily: Preferred, no PA, $0 EPSDT copay
• Stimulant refill requires monthly written prescription (Schedule II)
• PDMP checked at each prescription

If his pediatrician wants to use brand Concerta with DAW, PA is required and likely denied because generic methylphenidate ER is therapeutically equivalent. EPSDT does not override the generic substitution rule.

Cost to family: $0 per month for medication.

Worked example 5: Mr. Lopez, 55, hepatitis C diagnosis

Mr. Lopez is 55, on Georgia Medicaid via Pathways, diagnosed with chronic hepatitis C genotype 1a.

Treatment plan:

• Sofosbuvir-velpatasvir (Epclusa) 400-100 mg daily for 12 weeks
• This is a high-cost specialty antiviral

PA process:

• Prescriber submits PA to Mr. Lopez's pharmacy benefit (his CMO's PBM) with: HCV genotype, viral load, ALT/AST, FibroSure or liver biopsy, prior therapy history, substance use evaluation, treatment readiness
• PA approved within 7 days
• Filled through specialty pharmacy (mail order with cold-chain not required for these tablets)
• Specialty pharmacy provides adherence monitoring and refill coordination

Mr. Lopez pays a nominal brand copay per 28-day fill for the 3-fill, 12-week course, a very low total out-of-pocket cost.

Worked example 6: Mrs. Park, 62, opioid-naive, post-surgical pain

Mrs. Park is 62, on GA Medicaid ABD, and just had outpatient gallbladder surgery. Her surgeon prescribes:

• Oxycodone-acetaminophen 5/325 mg, take 1 every 4-6 hours as needed for pain, #28 (7-day supply)

PDMP check confirms she is opioid-naive. The 7-day initial supply limit applies under the SUPPORT Act. The prescription is filled for the 7-day quantity.

She picks up the prescription at her community pharmacy; as an ABD fee-for-service member, her claim is processed by OptumRx. Cost: nominal generic copay.

If she needs additional opioid days, the surgeon must reassess and write a new prescription. Refills are not automatic for Schedule II opioids.

Common mistakes Georgia members make

A few patterns recur in pharmacy operations.

Filling at an out-of-network pharmacy. A pharmacy must be enrolled in Georgia Medicaid and participate in your benefit's network (the OptumRx-administered FFS network, or your CMO's pharmacy network) to process your claim. Out-of-network pharmacies cannot bill your Medicaid pharmacy benefit.

Insisting on brand when generic is available. DAW PA is rarely approved. Accept the generic unless your prescriber has specifically documented a clinical reason.

Not requesting the 72-hour emergency supply when PA is pending. Federal law requires it; pharmacies sometimes need a reminder.

Calling the wrong place for pharmacy issues. Know which track you are on. CMO members should contact their CMO (the number on the member ID card) for pharmacy questions, because the CMO administers their pharmacy benefit. Fee-for-service members deal with the OptumRx-administered FFS benefit and can call DCH's member contact center at 1-866-211-0950 for help.

Not checking the PDL before assuming a drug is covered. Non-preferred drugs require PA. The PDL is published quarterly on the DCH Georgia Medicaid pharmacy program portal.

Missing the 24-hour PA standard. If the plan does not respond within 24 hours of complete information, the request is deemed approved with documentation.

Believing all dual-eligibles use Medicaid pharmacy. Full duals use Medicare Part D, not Medicaid pharmacy. The Medicaid pharmacy benefit applies only to Medicaid-only members.

Filling 30 days when 90 days is available. For stable maintenance medications, 90-day supplies save trips and copays.

Not using mail-order or specialty pharmacy when appropriate. Mail-order can save trips. Specialty pharmacy provides cold-chain shipping and clinical support.

Believing weight loss drugs are covered. Georgia Medicaid does not cover GLP-1 agonists for weight loss alone (covered for diabetes only with PA). Other weight loss drugs are also generally not covered.

Confusing PDL with the full Medicaid formulary. All drugs from rebate-participating manufacturers are technically covered; the PDL is the preferred-tier subset that does not require PA.

Missing the 30-day OSAH appeal deadline for denied PA. Late appeals are dismissed.

Filling controlled substances out of state. GA Medicaid pharmacy network is in-state; out-of-state pharmacy fills for controlled substances are generally not covered.

Not understanding the lock-in program. Members with patterns of controlled substance misuse may be assigned to a single prescriber and pharmacy. The lock-in is not punitive but is monitoring.

Believing all antiretrovirals or oncology drugs are open access. Many are; some are PA-restricted. Check before assuming.

Get help with Georgia Medicaid prescription drug coverage

If you have a prescription denial, a PA question, or trouble finding a covered drug, the resources below can help. For dual-eligibles, GeorgiaCares is the SHIP for Medicare Part D questions. For more about how Brevy researches and updates these guides, visit brevy.com.

Learn More

• Georgia Medicaid hub
• Georgia Medicaid pharmacy benefit manager
• Georgia Medicaid Preferred Drug List
• Georgia Medicaid prior authorization process
• Georgia Medicaid covered services overview
• Georgia Medicaid dual eligibles

Find personalized help navigating Georgia Medicaid pharmacy coverage at brevy.com.

The information on Brevy.com is for educational purposes only and is not a substitute for professional legal, financial, or medical advice. Rules vary by state and program and change frequently. Always verify with the relevant agency or a qualified professional. Brevy is not a law firm, financial advisor, or healthcare provider.